New potential to treat chronic obstructive pulmonary disease
Links shared publicly online about this topic.
- 1,426total visits
New potential to treat chronic obstructive pulmonary disease
View full resource at eurekalert.org
Tags: Breathing, Bronchitis, COPD, Disease and Condition, Antioxidant, Protein, Smoking Cessation, Pulmonology
Most Recently Shared on January 27, 2010 at 6:40 pm By:
New potential to treat chronic obstructive pulmonary disease : http://eurekalert.org/e/39Z1 #EurekAlert
Also Shared By:
New once-daily beta-agonist improves lung function in COPD - The Doctor's Channel
thedoctorschannel.com — “NEW YORK (Reuters Health) – An investigational long-acting beta-2-agonist, vilanterol, inhaled once-daily improves FEV1 significantly in patients with moderate-to-severe chronic obstructive pulmonary disease after a month of treatment, according to a report in Chest online January...” View full resource at thedoctorschannel.com
Most Recently Shared on January 24, 2012 at 11:23 pm By:
Dr Michael Banks - The Doctor's Channel Health Site
What are your thoughts of vilanterol used to treat FEV1? - From Reuters Health/TDC http://t.co/ECSgdWaq #pulmonary #health
Potential To Reverse Smoke-Induced Damage And Disease In The Lungs
medicalnewstoday.com — “By studying mice exposed to tobacco smoke for a period of months, researchers have new insight into how emphysema and chronic obstructive pulmonary disease (COPD) develops. In Cell, a Cell” View full resource at medicalnewstoday.com
Most Recently Shared on October 14, 2011 at 9:06 am By:
Potential To Reverse Smoke-Induced Damage And Disease In The Lungs: By studying mice exposed to tobacco smoke fo... http://t.co/MyS9rEjx
New Guidelines for Spotting, Treating COPD Released - Drugs.com MedNews
drugs.com — “Four of the world s leading pulmonary associations have issued new guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease, one of t” View full resource at drugs.com
Most Recently Shared on August 1, 2011 at 10:14 pm By:
Drugs and Devices OW OW Health
New Guidelines for Spotting, Treating COPD Released: MONDAY, Aug. 1 -- Four of the world's leading pulmona... http://bit.ly/pC6x1V #drug
Mist inhalers increase risk of death in patients with COPD
news-medical.net — “People who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease (COPD) may be 52 percent more likely to die, new Johns Hopkins-led research suggests.” View full resource at news-medical.net
Most Recently Shared on June 16, 2011 at 11:36 am By:
Mist inhalers increase risk of death in patients with COPD: People who use a mist inhaler to deliver a drug wide... http://bit.ly/iVbkMn
Researchers question safety of mist inhalers for delivering common drug for chronic lung disease
medicalxpress.com — “People who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease (COPD) may be 52 percent more likely to die, new Johns Hopkins-led research suggests.” View full resource at medicalxpress.com
Most Recently Shared on June 15, 2011 at 8:13 am By:
PhysOrg Health News Health News
Researchers question safety of mist inhalers for delivering common drug for chronic lung disease http://tw.medicalxpress.com/227329923
Researchers question safety of mist inhalers for delivering common drug for chronic lung disease
eurekalert.org — “People who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease may be 52 percent more likely to die, new Johns Hopkins-led research suggests.” View full resource at eurekalert.org
Most Recently Shared on June 15, 2011 at 1:41 am By:
Researchers question safety of mist inhalers for delivering common drug for chronic lung disease: People who use... http://bit.ly/iSQDxN
Safety concern with mist inhalers for delivering common drug for chronic lung disease
sciencedaily.com — “People who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease may be 52 percent more likely to die, new research suggests.” View full resource at sciencedaily.com
Most Recently Shared on June 15, 2011 at 1:38 am By:
Safety concern with mist inhalers for delivering common drug for chronic lung disease http://bit.ly/l4AMMJ
Researchers Question Safety of Mist Inhalers for Delivering Common Drug for Chronic Lung Disease
newswise.com — “People who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease (COPD) may be 52 percent more likely to die, new Johns Hopkins-led research suggests.” View full resource at newswise.com
Most Recently Shared on June 14, 2011 at 11:25 pm By:
newswise Health Communicator and Health News
Researchers Question Safety of Mist Inhalers for Delivering Common Drug for Chronic Lung Disease: People who use... http://bit.ly/iUIRD6
NIH-Funded Study Unveils Potential Genetic Links to Lung Disease Risk | Highlight HEALTH
highlighthealth.com — “A new study involving data from more than 20,000 individuals has uncovered several DNA sequences linked to impaired pulmonary function. The research, an analysis that combined the results of several smaller studies, provides insight into the mechanisms involved in reaching full lung capacity. The findings may ultimately lead to better understanding of lung function and diseases like asthma and chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States.” View full resource at highlighthealth.com
Most Recently Shared on June 5, 2011 at 7:00 am By:
Walter Jessen - Highlight HEALTH Health Organization and Health Executive
NIH-Funded Study Unveils Potential Genetic Links to Lung Disease Risk | Highlight HEALTH http://ow.ly/58bJE
Chronic Obstructive Pulmonary Disease Drugs May Cause Higher Urinary Retention in Men | ThirdAge
thirdage.com — “A new study finds that men with chronic obstructive pulmonary disease who are treated through inhaled anticholinergic drugs have an increased likelihood of developing urinary problems.” View full resource at thirdage.com
Most Recently Shared on May 24, 2011 at 3:44 pm By:
Chronic Obstructive Pulmonary Disease Drugs May Cause Higher Urinary Retention in Men http://bit.ly/ifMCQA
COPD drugs linked to urinary problems in men, study finds - McKnight's Long Term Care News
mcknights.com — “A specific class of drugs used to treat chronic obstructive pulmonary disease may result in urinary problems for patients, new research finds.” View full resource at mcknights.com
Most Recently Shared on May 24, 2011 at 1:09 pm By:
McKnight's LTC News Health News and Medical Publisher
COPD drugs linked to urinary problems in men, study finds http://bit.ly/iNHp1f #healthcare
Certain COPD Meds Linked to Urinary Troubles in Men - iVillage
ivillage.com — “MONDAY, May 23 (HealthDay News) -- New research suggests that a certain class of drugs used to treat chronic obstructive pulmonary disease (COPD) boosts the risk that male patients will be unable to urinate. The disease, which makes breathing” View full resource at ivillage.com
Most Recently Shared on May 23, 2011 at 11:42 pm By:
Certain COPD Meds Linked to Urinary Troubles in Men http://dlvr.it/SlKpX
Late-breaking clinical trials
eurekalert.org — “Results from C91 "Late-Breaking Clinical Trials" on Tuesday afternoon, May 17, will bring new light to clinical problems and potential treatments. While five examine possible new therapies for people with asthma (pregnant women), emphysema, lymphangioleiomyomatosis, TB and chronic obstructive pulmonary disease, a sixth looks at the safety of physician- vs. nurse-led transport teams for critically ill patients,” View full resource at eurekalert.org
Most Recently Shared on May 17, 2011 at 9:00 pm By:
Late-breaking clinical trials: Results from C91 "Late-Breaking Clinical Trials" on Tuesday afternoon, May 17, wi... http://bit.ly/lVmJyn
Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment - Drugs.com MedNews
drugs.com — “New class of dual action long-acting Muscarinic Antagonist Beta-2 Agonist (MABA) has potential to change the paradigm of COPD treatment Almirall is aiming at st” View full resource at drugs.com
Most Recently Shared on April 11, 2011 at 7:08 pm By:
Drugs and Devices OW OW Health
Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Dise... http://bit.ly/epp6MS #drug
Patients with COPD have higher risk of shingles, study finds
sciencedaily.com — “Patients with chronic obstructive pulmonary disease (COPD) are at greater risk of shingles compared with the general population, according to a new study. The risk is greatest for patients taking oral steroids to treat COPD.” View full resource at sciencedaily.com
Most Recently Shared on February 23, 2011 at 1:14 pm By:
Patients with COPD have higher risk of shingles, study finds: Patients with chronic obstructive pulmonary diseas... http://bit.ly/gd9fwi
Advertisement
science news
@eurekalert
AAAS New potential to treat chronic obstructive pulmonary disease http://bit.ly/awVgZE
1 year ago...